Fig. 3From: Severe nivolumab-induced pneumonitis preceding durable clinical remission in a patient with refractory, metastatic lung squamous cell cancer: a case reportComparison of functional genomic alterations by FoundationOne assay. Graphic comparison of MAF% for each functional genomic alteration detected by FoundationOne targeted exome sequencing assay in the initial (column A), recurrent and metastatic (columns B and C), and post-treatment, relapsed tumor (column D)Back to article page